Boston – DPS Group announced that Jim Grunwald, senior vice president of U.S. business development, has received the Hank Moes Award from the Boston Chapter of the International Society for Pharmaceutical Engineering (ISPE Boston).
The Hank Moes Award is presented to a Boston Area Chapter member in recognition of a comprehensive body of work and specific accomplishments that are widely recognized as truly extraordinary and of positive and lasting impact on ISPE, the Boston Area Chapter, and the life sciences/biopharmaceutical industry.
Grunwald has a long-standing legacy of supporting ISPE, specifically the Boston chapter. As an ISPE member for over 30 years, his contributions include serving as president of the board of directors in 2010, chairing the Product Show Committee and Educational Planning Committee, founding the former Young Professionals group (currently the Emerging Leaders), and serving as meeting manager and primary planner of educational and social events including many golf outings and the annual ski trip. At the international level, he has served on the facility of the year award (FOYA) committee, contributed heavily to annual meeting planning, and served on ISPE’s North and South American Affiliate Council (NASAAC).
Grunwald has more than 30 years of experience in the AEC industry. He joined DPS Group in 2015 and previously served as vice president of strategic development for Boston’s project operations. In this role, he led teams and delivered strategic capital projects for biotech/pharmaceutical and advanced technology clients. He supports all of DPS’ internal and external client relationships with expert guidance in the areas of planning, risk assessment, site selection, estimating, CQV, and operational readiness. He also has special expertise in strategic planning, real estate development, and risk assessments associated with capital projects and product development in the regulated industry and advanced technology sectors. Additionally, he fulfills the role of project sponsor for many of DPS’ strategic project initiatives, providing senior management oversight and guidance to project teams on behalf of clients including Moderna, Sanofi, Lonza, ThermoFisher, Biogen, Pfizer, and Waters Corporation.
“Jim has established himself as a presence and a leader in the life sciences industry in the greater Boston Area – it’s unlikely you will meet someone here in the industry who doesn’t know Jim,” said Tom Struble, past president of ISPE Boston and director of commissioning, qualification, and validation (CQV) at DPS Group. “His relentless energy and infectious enthusiasm have left a lasting impact on the local biopharma industry, and his stalwart support of ISPE has molded the Boston Area Chapter into the massive success it is today.”